Dr. Toby J. Briskin

Endocrinology
Kaiser Permanente
19999 Rockside Rd, 
Bedford, OH 
Accepting New Patients
Referral required
Before you request
Kaiser Permanente
19999 Rockside Rd, 
Bedford, OH 

Overview

Toby Briskin is an Endocrinologist practicing medicine in Bedford, Ohio.

Her clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Obesity.

She is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 12 clinical trials. Dr. Briskin is currently accepting new patients.

Specialties

Endocrinology

Licenses

Internal Medicine in OH

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Kaiser Permanente
19999 Rockside Rd, Bedford, OH 44146

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Long-Term Nicotine Treatment of Mild Cognitive Impairment
Long-Term Nicotine Treatment of Mild Cognitive Impairment
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Nicotine Transdermal Patch
Study Phase: Phase 2
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 3
A Phase 2, Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Dose-Ranging Trial to Determine the Safety, Immunogenicity and Efficacy of an Adenoviral-Vector Based Vaccine Expressing Severe Acute Respiratory Syndrome (SARS-CoV-2) and dsRNA Adjuvant Administered Orally
A Phase 2, Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Dose-Ranging Trial to Determine the Safety, Immunogenicity and Efficacy of an Adenoviral-Vector Based Vaccine Expressing Severe Acute Respiratory Syndrome (SARS-CoV-2) and dsRNA Adjuvant Administered Orally
Enrollment Status: Terminated
Publish Date: April 13, 2025
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
View 9 Less Clinical Trials

2 Total Publications

Correction to: Evaluating the User Performance and Experience with a Re-Engineered 4mm × 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles.
Correction to: Evaluating the User Performance and Experience with a Re-Engineered 4mm × 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: April 19, 2019
Similar Doctors
Expertise in
43
conditions
Expertise in
43
conditions
Referral required
Before you request

Office

3909 Orange Pl Ste 3100, 
Beachwood, OH 
 (4.0 miles away)
216-896-1774
Languages Spoken:
English, French, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Betul Hatipoglu is an Endocrinologist practicing medicine in Beachwood, Ohio. Dr. Hatipoglu is highly rated in 43 conditions, according to our data. Her clinical expertise encompasses Cushing's syndrome, Cushing's disease, Type 1 Diabetes (T1D), Islet Cell Transplantation, and Pancreatectomy. Dr. Hatipoglu is currently accepting new patients.

Expertise in
42
conditions
Dr. Divya Yogi-Morren
Endocrinology
Expertise in
42
conditions
Dr. Divya Yogi-Morren
Endocrinology
Referral required
Before you request

Cleveland Clinic

9500 Euclid Ave, 
Cleveland, OH 
 (7.8 miles away)
216-445-5411
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Divya Yogi-Morren is an Endocrinologist practicing medicine in Cleveland, Ohio. Dr. Yogi-Morren is highly rated in 42 conditions, according to our data. Her clinical expertise encompasses Pituitary Tumor, Prolactinoma, Cushing's disease, and Empty Sella Syndrome. Dr. Yogi-Morren is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral required
Before you request

Twinsburg Family Health And Surgery Center

8701 Darrow Road, 
Twinsburg, OH 
 (9.0 miles away)
330-888-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kevin Pantalone is an Endocrinologist practicing medicine in Twinsburg, Ohio. Dr. Pantalone is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Newborn Low Blood Sugar, and Hypothyroidism. Dr. Pantalone is board certified in American Board Of Internal Medicine, 2011. Dr. Pantalone is currently accepting new patients.

Frequently Asked Questions about Dr. Toby J. Briskin

How do I make an appointment with Dr. Toby J. Briskin?

You can book an appointment with Dr. Toby J. Briskin by calling their office at 216-524-7377. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Toby J. Briskin a top-rated expert for Maturity Onset Diabetes of the Young?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Toby J. Briskin is classified as an Experienced expert for Maturity Onset Diabetes of the Young, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Toby J. Briskin specialize in?

While Dr. Toby J. Briskin is a Endocrinology, they have specific expertise in Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Obesity. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Toby J. Briskin participate in research or clinical trials?

Yes. Dr. Toby J. Briskin has published 2 articles and abstracts on conditions like Maturity Onset Diabetes of the Young. You can view a list of Dr. Toby J. Briskin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Briskin's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile